May 14 through 20th is National Women’s Health Week! Meridien Research knows that research on women’s health is critically important. Disease can manifest differently in women than in men and women frequently respond differently to Food and Drug Administration (FDA) approved treatments. According to the FDA website, ‘medical products can affect men and women differently. Sometimes women have different side effects. It is important that women participate to show if products are safe and work well in both men and women.’
In 1994, the FDA’s Office of Women’s Health (OWH) established a program to support FDA research and development related to the science of women’s health. The projects in this program have addressed health issues affecting women throughout their lives.
When it comes to research, women are already in clinical trials. However, women from diverse backgrounds still need to participate. The FDA (and Meridien Research) encourage women of all ages, racial and ethnic groups, and women with disabilities or chronic health conditions to consider joining a clinical trial or medical research study.
Some of the clinical research trials include: endocrine and metabolic disorders, cardiovascular disease, breast cancer, sexually transmitted infections, and issues related to pregnancy. Results from this research have led to safety labeling changes for some products, guidance on product development, and regulatory decisions related to FDA-regulated products used by women.
Research concerning women’s health has grown through the OWH and National Institute of Health’s (NIH) advocacy and through pharmaceutical companies’ investing into new and promising therapies. It’s through the advocacy and importance placed on gender differences in clinical research that has made a substantial difference in the lives of women throughout the United States.
Meridien Research has performed countless studies focused on women’s health and continues to support gender-based research. Today, more than ever, women can take control of their personal health. For information about our currently enrolling research studies for endometriosis, uterine fibroids and others, please call 888-777-8839 or submit an inquiry to email@example.com.